BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19047685)

  • 1. Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers.
    Kuk C; Kulasingam V; Gunawardana CG; Smith CR; Batruch I; Diamandis EP
    Mol Cell Proteomics; 2009 Apr; 8(4):661-9. PubMed ID: 19047685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mining the malignant ascites proteome for pancreatic cancer biomarkers.
    Kosanam H; Makawita S; Judd B; Newman A; Diamandis EP
    Proteomics; 2011 Dec; 11(23):4551-8. PubMed ID: 21932441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive proteome analysis of ovarian cancers using liquid phase separation, mass mapping and tandem mass spectrometry: a strategy for identification of candidate cancer biomarkers.
    Wang H; Kachman MT; Schwartz DR; Cho KR; Lubman DM
    Proteomics; 2004 Aug; 4(8):2476-95. PubMed ID: 15274142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ascites May Provide Useful Information for Diagnosis of Ovarian Cancer].
    Stuchlíková E; Zahradníková M; Nenutil R; Valík D; Vojtěšek B; Novotný M; Hernychova L
    Klin Onkol; 2017; 30(Supplementum1):187-190. PubMed ID: 28471203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human kallikreins 6 and 10 in ascites fluid from ovarian cancer patients.
    Luo LY; Soosaipillai A; Grass L; Diamandis EP
    Tumour Biol; 2006; 27(5):227-34. PubMed ID: 16864975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers.
    Gortzak-Uzan L; Ignatchenko A; Evangelou AI; Agochiya M; Brown KA; St Onge P; Kireeva I; Schmitt-Ulms G; Brown TJ; Murphy J; Rosen B; Shaw P; Jurisica I; Kislinger T
    J Proteome Res; 2008 Jan; 7(1):339-51. PubMed ID: 18076136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Significance of Peptidome in Human Ovarian Cancer for Patients With Ascites.
    Huang X; Zhou J; Tang R; Han S; Zhou X
    Int J Gynecol Cancer; 2018 Feb; 28(2):355-362. PubMed ID: 29240604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative proteome analysis of ovarian cancer tissues using a iTRAQ approach.
    Wang LN; Tong SW; Hu HD; Ye F; Li SL; Ren H; Zhang DZ; Xiang R; Yang YX
    J Cell Biochem; 2012 Dec; 113(12):3762-72. PubMed ID: 22807371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer.
    Gunawardana CG; Kuk C; Smith CR; Batruch I; Soosaipillai A; Diamandis EP
    J Proteome Res; 2009 Oct; 8(10):4705-13. PubMed ID: 19663500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new method for isolation of interstitial fluid from human solid tumors applied to proteomic analysis of ovarian carcinoma tissue.
    Haslene-Hox H; Oveland E; Berg KC; Kolmannskog O; Woie K; Salvesen HB; Tenstad O; Wiig H
    PLoS One; 2011 Apr; 6(4):e19217. PubMed ID: 21541282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
    Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
    Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of multiple novel protein biomarkers shed by human serous ovarian tumors into the blood of immunocompromised mice and verified in patient sera.
    Beer LA; Wang H; Tang HY; Cao Z; Chang-Wong T; Tanyi JL; Zhang R; Liu Q; Speicher DW
    PLoS One; 2013; 8(3):e60129. PubMed ID: 23544127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-Linked glycome and proteome of high-molecular-mass proteins in human ovarian cancer ascites: Identification of sulfation, disialic acid and O-linked fucose.
    Karlsson NG; McGuckin MA
    Glycobiology; 2012 Jul; 22(7):918-29. PubMed ID: 22422444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling signatures of ovarian cancer tumour suppression using 2D-DIGE and 2D-LC-MS/MS with tandem mass tagging.
    Sinclair J; Metodieva G; Dafou D; Gayther SA; Timms JF
    J Proteomics; 2011 Apr; 74(4):451-65. PubMed ID: 21237297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology.
    Fredolini C; Meani F; Luchini A; Zhou W; Russo P; Ross M; Patanarut A; Tamburro D; Gambara G; Ornstein D; Odicino F; Ragnoli M; Ravaggi A; Novelli F; Collura D; D'Urso L; Muto G; Belluco C; Pecorelli S; Liotta L; Petricoin EF
    AAPS J; 2010 Dec; 12(4):504-18. PubMed ID: 20549403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial peptide libraries facilitate development of multiple reaction monitoring assays for low-abundance proteins.
    Drabovich AP; Diamandis EP
    J Proteome Res; 2010 Mar; 9(3):1236-45. PubMed ID: 20070123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry.
    Elschenbroich S; Ignatchenko V; Clarke B; Kalloger SE; Boutros PC; Gramolini AO; Shaw P; Jurisica I; Kislinger T
    J Proteome Res; 2011 May; 10(5):2286-99. PubMed ID: 21491939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteome-metabolome profiling of ovarian cancer ascites reveals novel components involved in intercellular communication.
    Shender VO; Pavlyukov MS; Ziganshin RH; Arapidi GP; Kovalchuk SI; Anikanov NA; Altukhov IA; Alexeev DG; Butenko IO; Shavarda AL; Khomyakova EB; Evtushenko E; Ashrafyan LA; Antonova IB; Kuznetcov IN; Gorbachev AY; Shakhparonov MI; Govorun VM
    Mol Cell Proteomics; 2014 Dec; 13(12):3558-71. PubMed ID: 25271300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ovarian cancer-derived secretory/releasing proteome: A repertoire of tumor markers.
    Zhang Y; Xu B; Liu Y; Yao H; Lu N; Li B; Gao J; Guo S; Han N; Qi J; Zhang K; Cheng S; Wang H; Zhang X; Xiao T; Wu L; Gao Y
    Proteomics; 2012 Jun; 12(11):1883-91. PubMed ID: 22623176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ascites N-glycome of epithelial ovarian cancer patients.
    Biskup K; Braicu EI; Sehouli J; Tauber R; Blanchard V
    J Proteomics; 2017 Mar; 157():33-39. PubMed ID: 28188862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.